Skip to main content
Clinical Trials/CTRI/2021/08/036041
CTRI/2021/08/036041
Not yet recruiting
Phase 2

A quasi-experimental study comparing dysphagia optimized intensity modulated radiotherapy (Do-IMRT) versus standard intensity modulated radiotherapy (S-IMRT).

Karthik Subramaniam Thiagarajan0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C00-D49- Neoplasms
Sponsor
Karthik Subramaniam Thiagarajan
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Karthik Subramaniam Thiagarajan

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with stage T2\-T4, N\+, M0 carcinoma of oropharynx, hypopharynx or larynx with squamous cell carcinoma histology only
  • 2\) ECOG performance 0\-2
  • 3\) Written informed consent.

Exclusion Criteria

  • Patients with head and neck cancer with non\-squamous cell carcinoma histology
  • Cancer sites other than oropharynx, hypopharynx, or supraglottic larynx
  • Patients with T1 N0 M0 (or M1\) disease in the above\-mentioned sites
  • Patients with recurrent cancer in the above\-mentioned sites
  • Patients not fit for concurrent chemoradiation (or receiving chemotherapy other than weekly cisplatin)
  • Documented evidence of pre\-existing swallowing dysfunction (not related to cancer)
  • Previous radiotherapy to the head and neck region
  • ECOG performance 3\-4

Outcomes

Primary Outcomes

Not specified

Similar Trials